Cargando…
Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment
BACKGROUND: Niemann–Pick disease type C (NPC) is a fatal neurodegenerative disorder caused by abnormal intracellular cholesterol trafficking. Cyclodextrins (CDs), the most promising therapeutic candidates for NPC, but with concerns about ototoxicity, are cyclic oligosaccharides with dual functions o...
Autores principales: | Yamada, Yusei, Fukaura‐Nishizawa, Madoka, Nishiyama, Asami, Ishii, Akira, Kawata, Tatsuya, Shirakawa, Aina, Tanaka, Mayuko, Kondo, Yuki, Takeo, Toru, Nakagata, Naomi, Miwa, Toru, Takeda, Hiroki, Orita, Yorihisa, Motoyama, Keiichi, Higashi, Taishi, Arima, Hidetoshi, Seki, Takahiro, Kurauchi, Yuki, Katsuki, Hiroshi, Higaki, Katsumi, Minami, Kentaro, Yoshikawa, Naoki, Ikeda, Ryuji, Matsuo, Muneaki, Irie, Tetsumi, Ishitsuka, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449817/ https://www.ncbi.nlm.nih.gov/pubmed/37620691 http://dx.doi.org/10.1002/ctm2.1350 |
Ejemplares similares
-
Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice
por: Fukaura, Madoka, et al.
Publicado: (2021) -
Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann–Pick Type C disease models()
por: Tanaka, Yuta, et al.
Publicado: (2014) -
In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C
por: Yasmin, Nushrat, et al.
Publicado: (2019) -
In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease
por: Maeda, Yuki, et al.
Publicado: (2019) -
Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells
por: Hoque, Sanzana, et al.
Publicado: (2020)